Bixiye
QP10-25 Omada for Prevention
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Natiijooyinka Raadinta
Soo bandhiga 2981 - 2990 ee natiijooyinka 4229
Bixiye
QP11-25 Omada for Diabetes Management
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Bixiye
QP12-25 Omada for Hypertension Management
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Bixiye
QP13-25 Billing Guidelines for Providers in Contiguous Counties and Ancillary Claims
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Bixiye
QP14-25 MHCP Pharmacy Benefit Exclusion for Bizengri® and Opdivo Qvantig™
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Bixiye
QP15-25 Commercial Pharmacy Benefit Exclusion for Wezlana™
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Bixiye
QP16-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective April 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Bixiye
QP17-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective March 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025
Bixiye
QP18-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2025